Effect of first-line treatment on second primary malignancies and Richter’s transformation in patients with CLL

Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia

(2014) John C. Byrd et al.   NEW ENGLAND JOURNAL OF MEDICINE

Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia

(2014) Richard R. Furman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical characteristics and long-term outcome of young hairy cell leukemia patients treated with cladribine: a single-institution series

(2013) J. D. Rosenberg et al.   BLOOD

Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients

(2013) Sameer A. Parikh et al.   BRITISH JOURNAL OF HAEMATOLOGY

Bendamustine in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group

(2012) Kirsten Fischer et al.   JOURNAL OF CLINICAL ONCOLOGY

Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function

(2012) D J DiLillo et al.   LEUKEMIA

Long-Term Cancer Risk of Immunosuppressive Regimens after Kidney Transplantation

(2010) M. P. Gallagher et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

(2010) M Hallek et al.   LANCET

First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia

(2009) B. F. Eichhorst et al.   BLOOD

Other Malignancies in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

(2008) Apostolia-Maria Tsimberidou et al.   JOURNAL OF CLINICAL ONCOLOGY